The U.S. Food and Drug Administration on Wednesday cleared Regeneron Pharmaceuticals’ immunotherapy, Libtayo, as an add-on treatment for skin cancer patients at high risk of their disease returning ...
16h
PharmaTher Holdings Ltd.: PharmaTher Provides Update on Ketamine Program for LID-Parkinson's Disease
Phase 3 program targeting a potential US$2.2B U.S. market opportunity505(b)(2) regulatory path leveraging prior human data to reduce risk, cost, and timeFDA-reviewed CMC package validated through prio ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”), a specialty pharmaceutical company focused on unlocking ...
DPA International on MSN
Alzheimer's drug shows promise for teens with autism
A drug originally developed to treat Alzheimer's disease may also help teenagers with autism improve their communication ...
HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder (ASD), according to a study published online October 1 in JAMA Network Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback